Literature DB >> 11845808

Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection.

Livia Biancone, Giovanna Del Vecchio Blanco, Francesco Pallone, Fabiana Castiglione, Giampaolo Bresci, Giancarlo Sturniolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11845808     DOI： 10.1053/gast.2002.31602

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

1.  Treatment of chronic hepatitis C in patients with Crohn's disease.

Authors:  Jill Gaidos; Virginia Clark; John F Valentine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

Review 2.  Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

Authors:  L H Calabrese; N N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

3.  Progression of viraemia during treatment with infliximab in a patient with rheumatoid arthritis and chronic hepatitis C infection.

Authors:  Hiroshi Uda; Makihiko Kuhara; Norihiro Nishimoto; Osamu Saiki
Journal:  BMJ Case Rep       Date:  2009-08-10

Review 4.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

5.  A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier.

Authors:  Joong Ho Bae; Joo Hyun Sohn; Hye Soon Lee; Hye Sun Park; Yil Sik Hyun; Tae Yeob Kim; Chang Soo Eun; Yong Cheol Jeon; Dong Soo Han
Journal:  Clin Mol Hepatol       Date:  2012-06-26

6.  Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho university hospital.

Authors:  Yolanda Faia Manhaes Tolentino; Homero Soares Fogaca; Cyrla Zaltman; Lia Laura Lewis Ximenes; Henrique Sergio Moraes Coelho
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

7.  Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.

Authors:  Alina M Allen; W Ray Kim; Joseph Larson; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

8.  Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.

Authors:  M Esteve; C Saro; F González-Huix; F Suarez; M Forné; J M Viver
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 9.  The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease.

Authors:  Ming Valerie Lin; Wojciech Blonski; Anna M Buchner; K Rajender Reddy; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2012-11-20       Impact factor: 3.199

Review 10.  Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.

Authors:  Stefano Sansone; Maria Guarino; Fabiana Castiglione; Antonio Rispo; Francesco Auriemma; Ilaria Loperto; Matilde Rea; Nicola Caporaso; Filomena Morisco
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.